[PR Newswire] – NEW YORK, Feb. 28, 2014 /PRNewswire/ — Juan E. Monteverde , a partner at Faruqi & Faruqi, LLP , a leading national securities firm headquartered in New York City, is investigating the Board of Directors … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring […]
[Accesswire] – Advaxis Inc. (NASDAQ:ADXS) today published a new blog post on The Chairman’s Blog, written by the company’s CSO, Dr. Robert Petit. TheChairmansBlog.com is an exclusive online media publication that provides … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
[GlobeNewswire] – PRINCETON, N.J. — Advaxis, Inc. , a biotechnology company developing the next generation of cancer immunotherapies, announced that it will participate in the Canaccord Genuity Orphan Drug One-on-One Day, … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
[GlobeNewswire] – PRINCETON, N.J. — Advaxis, Inc. , a biotechnology company developing the next generation of cancer immunotherapies, announced that Robert G. Petit, Ph.D., Chief Scientific Officer of Advaxis, will be … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
[PR Newswire] – AMSTERDAM, February 11, 2014 /PRNewswire/ — – SynCo’s live microbial track record, GMP scale-up and commercial manufacturing capabilities will facilitate the advancement of Advaxis’ ADXS-HPV program – … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
[GlobeNewswire] – PRINCETON, N.J. — Advaxis, Inc. , a biotechnology company developing the next generation of cancer immunotherapies, and SynCo Bio Partners B.V. (SynCo), one of the leading GMP contract manufacturers of … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
[Business Wire] – PRINCETON, N.J.–(BUSINESSWIRE)– Advaxis, Inc ., (OTCBB: ADXS) (“Advaxis†or the “Companyâ€), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to view […]
[at noodls] – Advaxis, Inc., (OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced it will present at the 6th Annual OneMedForum on January 8th at … moreView todays social media effects on ADXSView the latest stocks trending across Twitter. Click to view dashboardSee who Advaxis is hiring next, click here to […]
